Current Edition

Successful Post COVID-19 Disinfection Was Conducted in a Major Pharmaceutical Manufacturing Facility, China
Volume 12 Issue 2

Successful Post COVID-19 Disinfection Was Conducted in a Major Pharmaceutical Manufacturing Facility, China

Following the COVID-19 lockdown, environmental monitoring at a major international provider of biologics contractdevelopment and manufacturing organisation (CDMO) se...
Continue Reading →
Controlled Drug Regulation in Russia: A Regulatory Factsheet
Volume 12 Issue 2

Controlled Drug Regulation in Russia: A Regulatory Factsheet

This article reviews the regulatory requirements of controlled drugs in Russia with the help of a factsheet, and also provides an insight into the changes in Russian...
Continue Reading →
Reaping the Rewards of Structured Content Management in R&D Regulatory Operations: Preparation is Everything
Volume 12 Issue 2

Reaping the Rewards of Structured Content Management in R&D Regulatory Operations: Preparation is Everything

Investing in structured content management and authoring capabilities without making sure there is a supporting backbone first is a bit like owning a Porsche when th...
Continue Reading →
Pharma Firms Will Need Academic Expertise Like Never Before in the Post-COVID World
Volume 12 Issue 2

Pharma Firms Will Need Academic Expertise Like Never Before in the Post-COVID World

In recent weeks, much has been made of the challenges arriving at a global consensus around the response to the coronavirus pandemic. However, one area for encourage...
Continue Reading →
The Vital Role of Translation within Pharmaceuticals During COVID-19
Volume 12 Issue 2

The Vital Role of Translation within Pharmaceuticals During COVID-19

The world has become accustomed to accessible vaccines that enable us to enjoy longer, healthier lives. The majority of people have grown up being able to get the va...
Continue Reading →
Successful Marketing of Medicinal Cannabis and Cannabis-derived Products
Volume 12 Issue 2

Successful Marketing of Medicinal Cannabis and Cannabis-derived Products

The European Union (EU) is missing a harmonised law on medical and, if appropriate, recreational use of cannabis. Barbara Siebertz and Ute Hegener at PharmaLex look ...
Continue Reading →
Guiding Drug Optimisation Using Deep Learning Imputation and Compound Generation
Volume 12 Issue 2

Guiding Drug Optimisation Using Deep Learning Imputation and Compound Generation

The use of machine learning (ML) methods is now commonplace in many disciplines and Artificial Intelligence (AI) is on the rise, promising better and smarter solutio...
Continue Reading →
Could Greater Diversity and Inclusion Improve Innovation in Pharma?
Volume 12 Issue 2

Could Greater Diversity and Inclusion Improve Innovation in Pharma?

The past few weeks and the response to the COVID-19 crisis have shown how vital the pharma industry is to the global economy and society. The big question is whether...
Continue Reading →
Dissolution Specifications for Oral Drug Products (IR, DR, ER) in the USA – A Regulatory Perspective
Volume 12 Issue 2

Dissolution Specifications for Oral Drug Products (IR, DR, ER) in the USA – A Regulatory Perspective

The development of a dissolution method with suitable specifications is a key part of any oral drug product control strategy. Dissolution testing is a highly importa...
Continue Reading →
Barriers in Medical Device Innovation
Volume 12 Issue 2

Barriers in Medical Device Innovation

The healthcare industry is extremely complex and, due to rising costs and patient demands, the medical care deliveryenvironment is under growing pressure. Such stres...
Continue Reading →